Follow us
Copyright 2024. Houston Methodist, Houston, TX. All rights reserved.
Precision Medicine
![dM_Covid_Vaccines_Variants_thumb.jpg](/image/12455851.1714604815000/dM_Covid_Vaccines_Variants_thumb.webp)
Variants, Vaccines and Vigilance
An updated look at circulating SARS-CoV-2 variants, with a dose of more effective vaccine booster scheduling, tailored by Houston Methodist researchers applying Mathematics in Medicine.
Read now
![dM_aortic_morphology_thumb.jpg](/image/8605571.1646675439000/dM_aortic_morphology_thumb.webp)
Precise measurements of the aortic morphologies are crucial for optimal endograft sizing
A retrospective study at Houston Methodist has identified the area of the aorta as the most important parameter to measure for endograft sizing to treat ascending thoracic aorta pathologies.
Read now
![dM_RNA_Therapeutics_Thumb_Image.jpg](/image/12614750.1637169811000/dM_RNA_Therapeutics_Thumb_Image.webp)
Read now
RNA therapeutics have the potential to transform standard patient care and actualize personalized medicine
RNA as a therapeutic molecule holds great power and the potential to alter the standard of care for patients, actualize personalized medicine, and have diverse applications.
New theranostic shows promise for treating triple-negative breast cancer
The radiolabeled 64Cu/177Lu-DOTA-diZD small synthetic molecule revolutionizes treatment strategies for primary and metastatic tumors in aggressive triple-negative breast cancer by targeting angiogenic receptors.
Read now![](/image/7047485.1613668584000/blue_small_right_arrow.svg)
Interleukin 9 secreting polarized T cells show potential in solid and liquid tumor treatment
A cancer patient’s T cells, engineered to carry a receptor found on the surface of malignant cells, can aggressively attack tumors - with the potential to revolutionize solid tumor treatment.
Read now![](/image/7047485.1613668584000/blue_small_right_arrow.svg)
![carfilzomibtherapy_thumb.jpg](/image/8296833.1627501978000/carfilzomibtherapy_thumb.webp)
Carfilzomib therapy may enhance longevity in lung transplant recipients
Carfilzomib therapy shows potential in improving patient outcomes and longevity.
Read now![](/image/7047485.1613668584000/blue_small_right_arrow.svg)